ATE167800T1 - Polymeres arzneimittelabgabesystem - Google Patents

Polymeres arzneimittelabgabesystem

Info

Publication number
ATE167800T1
ATE167800T1 AT91908995T AT91908995T ATE167800T1 AT E167800 T1 ATE167800 T1 AT E167800T1 AT 91908995 T AT91908995 T AT 91908995T AT 91908995 T AT91908995 T AT 91908995T AT E167800 T1 ATE167800 T1 AT E167800T1
Authority
AT
Austria
Prior art keywords
drug delivery
pct
delivery vehicles
sec
erodible
Prior art date
Application number
AT91908995T
Other languages
English (en)
Inventor
Nienyuan James Chang
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE167800T1 publication Critical patent/ATE167800T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84—Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
    • A61F2013/8447—Additives, e.g. for odour, disinfectant or pH control in using different incompatible substances
    • A61F2013/8452—Additives, e.g. for odour, disinfectant or pH control in using different incompatible substances being contained in microcapsules
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S526/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S526/936—Physiological use, e.g. pharmaceutical, veterinary, dental

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91908995T 1990-04-27 1991-04-19 Polymeres arzneimittelabgabesystem ATE167800T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51611090A 1990-04-27 1990-04-27

Publications (1)

Publication Number Publication Date
ATE167800T1 true ATE167800T1 (de) 1998-07-15

Family

ID=24054165

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91908995T ATE167800T1 (de) 1990-04-27 1991-04-19 Polymeres arzneimittelabgabesystem

Country Status (9)

Country Link
US (1) US5474780A (de)
EP (1) EP0537165B1 (de)
JP (1) JPH05507683A (de)
AT (1) ATE167800T1 (de)
AU (1) AU640232B2 (de)
CA (1) CA2079676A1 (de)
DE (1) DE69129696T2 (de)
IE (1) IE911413A1 (de)
WO (1) WO1991016869A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660851A (en) * 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
US6248720B1 (en) 1996-07-03 2001-06-19 Brown University Research Foundation Method for gene therapy using nucleic acid loaded polymeric microparticles
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
EP0840623B1 (de) 1995-07-21 2007-07-18 Brown University Research Foundation Zusammensetzungen zur gentherapie die nukleinsäure-beladenen polymer-mikropartikeln enthalten
US6003341A (en) 1996-12-10 1999-12-21 Bloom; Cary Device for making fiber couplers automatically
US6096328A (en) * 1997-06-06 2000-08-01 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
ATE285220T1 (de) 1999-07-02 2005-01-15 Procter & Gamble Zusammenstzungen enthaltend organosiloxan-harze zur freisetzung von mundpflegewirkstoffen und zur verlängerung der freisetzung
US6113678A (en) * 1999-09-23 2000-09-05 Xerox Corporation Hot melt inks containing polyanhydrides
EP1387671A1 (de) 2001-05-03 2004-02-11 MASSACHUSETTS EYE & EAR INFIRMARY Implantierbare arzneistoffverabreichungsvorrichtung und verwendung derselben
CA2456806C (en) * 2001-08-08 2011-10-18 Brown University Research Foundation Methods for micronization of hydrophobic drugs
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
WO2003049701A2 (en) * 2001-12-10 2003-06-19 Spherics, Inc. Methods and products useful in the formation and isolation of microparticles
US6993846B2 (en) * 2002-05-08 2006-02-07 Eveready Battery Company, Inc. Lubricating strip
US7939094B2 (en) * 2002-06-19 2011-05-10 Boston Scientific Scimed, Inc. Multiphase polymeric drug release region
ES2295647T3 (es) 2002-07-15 2008-04-16 Alcon, Inc. Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular.
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
JP4395439B2 (ja) * 2002-09-12 2010-01-06 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） 薬物標的の同定のための方法
FR2884253B1 (fr) * 2005-04-08 2007-06-22 Univ Lille Sciences Tech Materiaux monolithiques fonctionnalisables
EP1733744A1 (de) * 2005-06-17 2006-12-20 Ludwig-Maximilians-Universität München Methode, Farbstoff und Medikament zu färbern die innere Grenzmembran und/oder die Augenlinse
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
EP2437684B1 (de) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Wirkstofffreisetzung im vorderen augensegment
JP5989780B2 (ja) 2011-09-14 2016-09-07 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 眼挿入装置および方法
CN104736133B (zh) 2012-10-17 2020-07-10 宝洁公司 用于递送口腔护理活性物质的条带以及施用口腔护理活性物质的方法
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
EP3904468B1 (de) 2020-04-30 2022-10-19 Société BIC Verfahren zur herstellung von thermochromen wasserbasierten geltintenzusammensetzungen und thermochrome wasserbasierte geltintenzusammensetzungen daraus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993071A (en) * 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4249531A (en) * 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
EP0163696B1 (de) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Verwendung eines bioadhesives
GB8810951D0 (en) * 1988-05-09 1988-06-15 Innovata Biomed Ltd Buccal local anaesthetic
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions

Also Published As

Publication number Publication date
EP0537165B1 (de) 1998-07-01
WO1991016869A1 (en) 1991-11-14
AU640232B2 (en) 1993-08-19
DE69129696D1 (de) 1998-08-06
CA2079676A1 (en) 1991-10-28
AU7796391A (en) 1991-11-27
US5474780A (en) 1995-12-12
JPH05507683A (ja) 1993-11-04
EP0537165A4 (de) 1993-02-24
DE69129696T2 (de) 1999-02-25
IE911413A1 (en) 1991-11-06
EP0537165A1 (de) 1993-04-21

Similar Documents

Publication Publication Date Title
ATE167800T1 (de) Polymeres arzneimittelabgabesystem
ITMI922192A1 (it) Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
ATE142460T1 (de) Osteogene proteine enthaltende arzneimittel
ATE213153T1 (de) Lagerstabile arzneiformen
ES2009346A6 (es) Procedimiento de preparacion de composiciones farmaceuticas que contienen polipeptidos hidroinsolubles.
EP0643963A3 (de) Biologisch erodierbare Vorrichtung zur Verabreichung von Wirkstoffen.
IL119627A0 (en) Controlled-release pharmaceutical preparations
AU4786096A (en) Solid active agent preparations
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
CA2177772A1 (en) Pharmaceutical compositions containing irbesartan
DE69326350D1 (de) Pharmazeutische formulierung
HUT72974A (en) Polypeptide and anti-hiv agent prepared therefrom
ATE435294T1 (de) Verabreichung von biologisch aktiven polypeptiden
CA2286482A1 (en) Nkt cell-activating agents containing .alpha.-glycosylceramides
MY101784A (en) Novel pharmacological compounds
ZA94413B (en) Pharmaceutical formulation for the treatment of nicotine dependence
AU3078892A (en) Human interleukin-8 analogs
AU5673399A (en) Compositions and methods for treating intracellular infections
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
DE58906232D1 (de) Azelastin enthaltende Arzneimittel mit kontrollierter Wirkstoffabgabe.
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
CA2012123A1 (en) Transdermal System Exhibiting Graduated Drug Release and its Use for the Local or Systemic Administration of Active Substances
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties